Assessing Guardant Health (GH) Valuation After Analyst Upgrades And New Cancer Test Partnerships [Yahoo! Finance]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
See our latest analysis for Guardant Health. The recent analyst rating shifts, new cancer tests and the Italian hospital rollout have come alongside a sharp 90 day share price return of 71.97%. Meanwhile, the 1 year total shareholder return of 210.73% points to strong momentum over a longer stretch, despite a weaker 5 year total shareholder return of a 29.82% decline. If Guardant Health's move has caught your eye, this could be a good moment to see how it compares with other healthcare stocks that are also drawing attention. With shares at a fresh 52 week high, a value score of 2, an intrinsic discount of 36% and a small gap to analyst targets, the key question is whether Guardant Health is still mispriced or if the market is already pricing in future growth. Guardant Health's most followed narrative points to a fair value of roughly US$111.82, which sits just below the latest close at US$112.33, suggesting only a small valuation gap. Substantial regulatory, reimbursement,
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart PlatformBusiness Wire
- Guardant Health: Shield Colorectal Cancer Screening To Sustain Growth [Seeking Alpha]Seeking Alpha
- Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]Yahoo! Finance
- Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 ResultsBusiness Wire
- How Recent Analyst Targets Are Shaping The Evolving Story For Guardant Health (GH) [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 10/29/25 - Beat
GH
Sec Filings
- 1/16/26 - Form 4
- 1/16/26 - Form 4
- 1/12/26 - Form 8-K
- GH's page on the SEC website